Supported by Sentynl Therapeutics

Intended Audience: All neonatal nurses

NCC Codes: NNP2, NIC2, LRN3, MNN3, NNIC20

Learning Outcome: Learners will increase their knowledge about how to identify, evaluate and treat neonatal seizures.

Release Date: 9/6/2024

Expiration Date: 9/30/2027

Disclosures: No person with the potential to influence the content of this activity has declared a relevant financial relationship with an ineligible* company. Any exceptions to this disclosure are noted below.

Scott Guthrie, MD, FAAP is a consultant for ONY BioTech and for Infant Bacterial Therapeutics.

•Nothing in this presentation is relevant to those relationships.

All presentations where speakers have disclosed financial relationships with ineligible companies have been reviewed and any conflicts have been mitigated.

Click Here for Accreditation Information, Requirements for earning CNE contact hours, and Disclaimer.

*Ineligible companies are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Scott Guthrie MD

Professor of Pediatrics, Vanderbilt University School of Medicine

Appearances